Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · November 03, 2016

Elimination of Neoadjuvant Chemoradiotherapy in Favor of Neoadjuvant Multiagent Chemotherapy in Rectal Adenocarcinoma

Cancer

 

Additional Info

Disclosure statements are available on the authors' profiles:

Cancer
Can We Eliminate Neoadjuvant Chemoradiotherapy in Favor of Neoadjuvant Multiagent Chemotherapy for Select Stage II/III Rectal Adenocarcinomas: Analysis of the National Cancer Database
Cancer 2016 Oct 25;[EPub Ahead of Print], RJ Cassidy, Y Liu, K Patel, J Zhong, CE Steuer, DA Kooby, MC Russell, TW Gillespie, JC Landry

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading